Givinostat is a histone deacetylase inhibitor used as a pharmaceutical raw material. It is a compound investigated for its potential anti-inflammatory and antineoplastic activities, primarily in research and manufacturing contexts for Duchenne muscular dystrophy.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 497833-27-9
4-[[[[6-[(Diethylamino)methyl]-2-naphthalenyl]methoxy]carbonyl]amino]benzoic acid
pharmaceutical intermediate
Quisinostat
pharmaceutical raw material
Lurbinectedin
pharmaceutical raw material
Apocynin
pharmaceutical raw material
P-menth-6-ene-2,8-diol
pharmaceutical raw material
Dexamethasone
pharmaceutical raw material
[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate
YALNUENQHAQXEA-UHFFFAOYSA-N
CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO